Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Synthetic Biology

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluating the quality of tabular synthetic data in health care.

PLOS digital health·2026

Same author

Selecting medical research data platforms for translational biomedical research: a five-tier overview and requirement-weighted assessment framework.

Frontiers in digital health·2026

Same author

Scaling Electronic Consent for Research Integrated into Clinical Routine Processes.

Studies in health technology and informatics·2026

Same author

Accurate Yet Privacy-Preserving Determination of Case Numbers Across German University Hospital Health Data.

Studies in health technology and informatics·2026

Same author

A FHIR-Based Dashboard as an Integrated Research Patient Record and Quality Assurance Tool.

Studies in health technology and informatics·2026

Same author

Setting up a DataSHIELD Hub for the German Medical Informatics Initiative: Challenges and Lessons Learned.

Studies in health technology and informatics·2026

Search research articles

Related Experiment Video

Updated: Jun 21, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Synthetic datasets for open software development in rare disease research.

Ibraheem Al-Dhamari^1,2, Hammam Abu Attieh³, Fabian Prasser³

¹Medical Informatics Group, Berlin Institute of Health at Charité - Universitätsmedizin, Berlin, Germany. ibraheem@uni-koblenz.de.

Orphanet Journal of Rare Diseases

|July 15, 2024

Summary

This summary is machine-generated.

Researchers developed SynthMD, an open-source tool generating synthetic rare disease datasets. This aids in developing data-sharing methods and improving rare disease research by providing crucial data for system testing.

Keywords:

Development Evaluation Rare diseases Statistics Synthetic data

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

Related Experiment Videos

Last Updated: Jun 21, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

Area of Science:

Biomedical Informatics
Computational Biology
Health Data Science

Background:

Enhancing rare disease data availability is crucial for research.
Data sharing methods are challenged by the unique sensitivity of rare disease data.
A gap exists in both methods and data for rare disease research development.

Purpose of the Study:

To bridge the gap in rare disease data availability.
To provide synthetic datasets for developing data-sharing methods.
To establish a foundation for advancements in rare disease research.

Main Methods:

A hierarchical data generation approach was employed.
Publicly available statistics from US Census Bureau and CDC were utilized.
The open-source software SynthMD, implemented in Python, was used for data generation.

Main Results:

Three synthetic datasets were generated for Sickle Cell Disease, Cystic Fibrosis, and Duchenne Muscular Dystrophy.
The datasets reflect US population demographics and disease-specific statistics.
Generated datasets and source code are available as Open Data and Open Source Software.

Conclusions:

The synthetic datasets can initiate the development of methods and platforms for rare disease data.
Applications include testing information systems and privacy-enhancing technologies.
This work supports researchers and developers in advancing rare disease data accessibility.